TWiV 1032: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses predicting COVID-19 incidence using wastewater surveillance data, use of wastewater metrics to track COVID-19 in the US, wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties, association between duration of SARS-CoV-2 positivity and long COVID, rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care, effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing progression to severe COVID-19, NIH launching of several phase 2 long-COVID treatment trials. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Predicting COVID-19 incidence using wastewater surveillance data (CDC) Use of wastewater metrics to track COVID-19 in the US (JAMA) Wastewater-based epidemiology predicts COVID-19-induced new hospital admissions (Nature) Association between duration of SARS-CoV-2 positivity and long COVID (JID) Rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care (ACS) Effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing COVID-19 progression (Viruses) NIH has launched several phase 2 long-COVID treatment trials (NIH) Fatigue can shatter a person (Atlantic) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1032 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]